Concord Biotech Limited has informed the Exchange about Schedule of meet
CONCORDBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Concord Biotech Limited has informed the exchanges about a Q4FY26 Earnings Call scheduled for June 1, 2026 at 2:30 PM IST. The call will discuss the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. Key company representatives including CMD Sudhir Vaid, JMD/CEO Ankur Vaid, and CFO Raviraj Karia will participate in the call hosted by Ambit Capital. This filing is pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015.
Retail investors can dial into the call to listen to management commentary on Q4 and full-year FY26 performance. The actual financial results were likely announced separately prior to this call.